Ots1xbet 등록a Pharmaceutical Co., Ltd.

Ots1xbet 등록a Pharmaceutical Co., Ltd. (Ots1xbet 등록a) today held a groundbreaking ceremony for the start of construction on a new, state-of-the-art research facility, tentatively named the Osaka Pharmaceutical Research Institute. The facility will conduct research in medical-related fields on a site in Minoh City in the northwestern area of Osaka Prefecture.

Drug-related research and development in the Ots1xbet 등록a group of companies focuses on diseases related to the central nervous system and to the renal / cardiovascular systems, on oncology, and on infectious diseases such as influenza and the neglected disease of tuberculosis. Drugs created through in-house research contribute to the health of patients around the world. Ots1xbet 등록a presently conducts drug-discovery research in these areas at sites around the word located in Tokushima and Otsu, Japan; in Cambridge, 1xbet 등록; in suburban Boston, USA; and in Shanghai, China.

Ots1xbet 등록a's new research institute will pursue discovery research rooted in biologics such as gene and cell therapies, antibodies, and regenerative medicine. In addition, research will be done on other cutting-edge area in immunology, in digital technologies, and on small-molecule drugs.

The new site, amidst natural surround1xbet 등록gs, will be conducive to 1xbet 등록formation exchange and deeper forms of collaboration
(simulated image of build1xbet 등록g)

An area of the site will be operated as an open-lab concept to encourage horizontal collaborations with academic 1xbet 등록stitutions and venture companies that conduct world-class life science research 1xbet 등록 the vic1xbet 등록ity. This is expected to foster 1xbet 등록creased 1xbet 등록formation exchange and alliances.

The site will have facilities for process research and the manufacture of gene- and cell-based therapies and will be at the forefr1xbet 등록t of envir1xbet 등록mentally friendly site design.

Ots1xbet 등록a aims to commence research in the 26,000 square-meter (280,000 square-foot) building in the latter half of 2022. It is anticipated that approximately 200 people will be employed at the site.

The addition of the site 1xbet 등록 Osaka Prefecture will position the company to carry out more diversified research 1xbet 등록 parallel with the evolution and diversification of therapy pathways. Our aim is noth1xbet 등록g less than the realization of unprecedented 1xbet 등록novations.